about
Mnk kinase pathway: Cellular functions and biological outcomesTAB-1 modulates intracellular localization of p38 MAP kinase and downstream signalingEndotoxin-activated cultured neonatal rat cardiomyocytes express functional surface-associated interleukin-1alphaAltered interleukin-1 receptor antagonist and interleukin-18 mRNA expression in myocardial tissues of patients with dilatated cardiomyopathy.Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.Plasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarctionA heart that beats for 500 years: age-related changes in cardiac proteasome activity, oxidative protein damage and expression of heat shock proteins, inflammatory factors, and mitochondrial complexes in Arctica islandica, the longest-living noncolonTransfusion of fresh murine red blood cells reverses adverse effects of older stored red blood cells.Interleukin-1 beta and interleukin-18: regulation and activity in local inflammation.Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study).VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function.High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferationBrain cytokines and disease.Anti-inflammatory and immunomodulatory properties of Carica papaya.Development and validation of a house finch interleukin-1β (HfIL-1β) ELISA system.Neonatal stem cells exhibit specific characteristics in function, proliferation, and cellular signaling that distinguish them from their adult counterparts.Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity.Tenascin C upregulates interleukin-6 expression in human cardiac myofibroblasts via toll-like receptor 4Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease.
P2860
Q26865459-7EFE498E-4026-4115-BD83-67A6EF8E65DBQ28581551-8CBD2C84-D5EF-412B-BBB4-85BCA7CB97B4Q28583222-86C5BADD-BB45-4024-B43D-2C9B10410186Q30319742-B0A818E0-2EC3-42B6-BDDA-A2678FF1C76CQ33801215-C9CC70D0-39DC-40A2-9223-C3D2DA9EEB88Q34045555-81A23AD5-3677-4303-971E-F67F3D2DDE64Q34392563-41E3A654-2EE6-4316-8ACE-83581C7419C5Q35219113-377223B1-3A72-4334-AB6A-C8B13CD07628Q35755278-BA0B6BA0-AFF3-4165-8048-5BEEFA9F85FFQ36532549-9698D41B-39A1-4A0B-B1D8-EDB4B79FCB72Q37038759-11534409-08CF-4B7D-BB39-53940B90D798Q37217978-8ECB82FD-7E3E-4D38-B45A-C58555E69B29Q38777663-3CB74A27-722F-4466-A1EB-9DE53C180AAEQ38896690-8B5D0B8E-DD6C-415A-B6CA-15F2085265F8Q40074273-186D347F-A912-4878-AC2F-50366587F2BFQ42526382-A3F40764-F700-4FDA-B354-E038B1D5869AQ42703006-BAADB657-9016-4A21-93D9-59C352EF7E50Q42767722-5E1C8C49-F2CD-43FE-BCBE-A9EE963D40B0Q44204800-B8BA726A-00EC-4CB2-B3D6-FA750DBF736F
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Proinflammatory cytokines in heart disease.
@ast
Proinflammatory cytokines in heart disease.
@en
Proinflammatory cytokines in heart disease.
@nl
type
label
Proinflammatory cytokines in heart disease.
@ast
Proinflammatory cytokines in heart disease.
@en
Proinflammatory cytokines in heart disease.
@nl
prefLabel
Proinflammatory cytokines in heart disease.
@ast
Proinflammatory cytokines in heart disease.
@en
Proinflammatory cytokines in heart disease.
@nl
P356
P1433
P1476
Proinflammatory cytokines in heart disease.
@en
P2093
Pomerantz BJ
P304
P356
10.1159/000046960
P577
2001-01-01T00:00:00Z